Detalhe da pesquisa
1.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency.
J Allergy Clin Immunol Glob
; 3(2): 100234, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544577